JONATHAN EDWARD NUTT
Prescription History 1932789310
Student in an Organized Health Care Education/Training Program in Rochester, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JONATHAN EDWARD NUTT, an active Student in an Organized Health Care Education/Training Program specialist practicing in Rochester, NY. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 183 documented patient claims. Among these therapy options, the most frequently utilized medication is Levetiracetam, which accounts for 91 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Levetiracetam | 91 | $32.61 | ▲ More than typical |
About Levetiracetam: Levetiracetam is used to treat seizures (epilepsy). Show more ▾ It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have. A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent. In 2024, this provider wrote 91 Medicare prescriptions for Levetiracetam, about 1.7 times the volume of the typical New York prescriber of this medication (53.4). Medicare paid an average of $32.61 per fill, versus $31.52 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 130.2 30-Day Fills standardized to 30-day supplies 3,840 Days of Medication total across all patients in 2024 | |||
| Zonisamide | 24 | $57.59 | ▼ Less than typical |
About Zonisamide: Zonisamide is used with other medications to prevent and control seizures (epilepsy). Show more ▾ Zonisamide is a sulfonamide anticonvulsant and a carbonic anhydrase inhibitor. It is unknown how zonisamide works to prevent seizures. A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization. In 2024, this provider wrote 24 Medicare prescriptions for Zonisamide, about 74% of the volume of the typical New York prescriber of this medication (32.5). Medicare paid an average of $57.59 per fill, versus $33.85 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2024 | |||
| Divalproex Sodium ErDivalproex Sodium | 22 | $27.18▼ below NY avg | ▼ Less than typical |
About Divalproex Sodium Er: This medication is used to treat seizure disorders, mental/mood conditions (such as manic phase of bipolar disorder), and to prevent migraine headaches. Show more ▾ It works by restoring the balance of certain natural substances (neurotransmitters) in the brain. A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. In 2024, this provider wrote 22 Medicare prescriptions for Divalproex Sodium Er, about 60% of the volume of the typical New York prescriber of this medication (36.4). Medicare paid an average of $27.18 per fill, versus $51.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 24.7 30-Day Fills standardized to 30-day supplies 666 Days of Medication total across all patients in 2024 | |||
| Aimovig AutoinjectorErenumab-Aooe | 21 | $736.17▼ below NY avg | ▼ Less than typical |
About Aimovig Autoinjector: This medication is used to help prevent migraine. Show more ▾ This medication may work by changing the amounts of certain natural substances in the brain. Erenumab belongs to a class of drugs known as monoclonal antibodies. Preventing frequent migraine attacks can help improve your ability to concentrate and do your usual tasks. Anti-human calcitonin gene-related peptide monoclonal antibody for the prevention of migraine headaches. In 2024, this provider wrote 21 Medicare prescriptions for Aimovig Autoinjector, about 65% of the volume of the typical New York prescriber of this medication (32.1). Medicare paid an average of $736.17 per fill, versus $845.90 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| Carbidopa-LevodopaCarbidopa/Levodopa | 13 | $12.95▼ below NY avg | ▼ Less than typical |
About Carbidopa-Levodopa: This combination medication is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms (such as shakiness, stiffness, difficulty moving). Show more ▾ Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting. In 2024, this provider wrote 13 Medicare prescriptions for Carbidopa-Levodopa, about 20% of the volume of the typical New York prescriber of this medication (66.3). Medicare paid an average of $12.95 per fill, versus $29.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 18.8 30-Day Fills standardized to 30-day supplies 534 Days of Medication total across all patients in 2024 | |||
| Oxcarbazepine | 12 | $54.55 | ▼ Less than typical |
About Oxcarbazepine: Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy). Show more ▾ A carbamazepine derivative that acts as a voltage-gated sodium channel blocker. It is used for the treatment of PARTIAL SEIZURES with or without secondary generalization. It is also an inducer of CYTOCHROME P-450 CYP3A4. In 2024, this provider wrote 12 Medicare prescriptions for Oxcarbazepine, about a third of the volume of the typical New York prescriber of this medication (31.7). Medicare paid an average of $54.55 per fill, versus $50.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13.7 30-Day Fills standardized to 30-day supplies 411 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for JONATHAN EDWARD NUTT is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Student in an Organized Health Care Education/Training Program prescribing approach at this Rochester, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
